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In eukaryotic cells, RNA polymerase II (RNA pol II) transcription and pre-mRNA processing are
coordinated events. We have addressed how individual components of the transcription and
pre-mRNA processing machinery are organized during mitosis and subsequently recruited into
the newly formed daughter nuclei. Interestingly, localization studies of numerous RNA pol II
transcription and pre-mRNA processing factors revealed a nonrandom and sequential entry of
these factors into daughter nuclei after nuclear envelope/lamina formation. The initiation com-
petent form of RNA pol II and general transcription factors appeared in the daughter nuclei
simultaneously, but prior to pre-mRNA processing factors, whereas the elongation competent
form of RNA pol II was detected even later. The differential entry of these factors rules out the
possibility that they are transported as a unitary complex. Telophase nuclei were competent for
transcription and pre-mRNA splicing concomitant with the initial entry of the respective factors.
In addition, our results revealed a low turnover rate of transcription and pre-mRNA splicing
factors during mitosis. We provide evidence to support a model in which the entry of the RNA
pol II gene expression machinery into newly forming daughter nuclei is a staged and ordered
process.
INTRODUCTION
In eukaryotic cells, RNA polymerase II (RNA pol II) tran-
scription and pre-mRNA processing are coordinated events
that require finely tuned interactions among a large number
of proteins (Misteli and Spector, 1999; Maniatis and Reed,
2002; Orphanides and Reinberg, 2002; Proudfoot et al., 2002).
One fundamental feature of mammalian cell nuclei is that
many components of the RNA synthesis and processing
machinery are organized into compartments (Spector, 1993;
Lamond and Earnshaw, 1998; Misteli, 2000; Spector, 2001;
Hernandez-Verdun et al., 2002; Huang, 2002). The best char-
acterized nuclear compartment is the nucleolus where rRNA
synthesis and processing as well as preribosome assembly
takes place (Scheer and Hock, 1999; Hernandez-Verdun et
al., 2002; Huang, 2002). The nucleus is further divided into
other nonmembrane-enclosed compartments, including but
not limited to chromosome territories, nuclear speckles, Ca-
jal bodies, promyelocytic leukemia bodies, etc. (Spector,
1993, 2001; Lamond and Earnshaw, 1998; Gall, 2000). Active
transcription sites can be visualized by bromouridine
triphosphate (bromo-UTP) incorporation as several thou-
sand foci scattered throughout the nucleus that colocalize
with transcription factors, heterogeneous nuclear RNA-as-
sociated proteins (hnRNPs), and other RNA processing fac-
tors (Iborra et al., 1996; Pombo et al., 2000). However, these
sites are not generally coincident with the larger and less
abundant “nuclear speckles” where splicing factors are en-
riched. Mammalian interphase nuclei typically contain
20–50 nuclear speckles. By electron microscopy, the speck-
led pattern corresponds to interchromatin granule clusters
(IGCs) and perichromatin fibrils (Spector et al., 1983, 1991;
Fakan et al., 1984; Fakan, 1994). Each IG cluster is composed
of granules measuring 20–25 nm in diameter (Fakan and
Puvion, 1980; Spector, 1993). Biochemical purification of
IGCs from mouse liver nuclei revealed that IGCs contain
136 proteins (Mintz et al., 1999), a large number of which
are pre-mRNA processing factors. IGCs also contain tran-
scription factors (Larsson et al., 1995), a hyperphosphory-
lated form of RNA pol II (Bregman et al., 1995), and 3-
processing factors (Schul et al., 1998; Calado and Carmo-
Fonseca, 2000). Observations that splicing factors are
recruited from IGCs to transcription sites support the pos-
sibility that one function of IGCs is the assembly/modifica-
tion of spliceosomal components (Jime´nez-Garcia and Spec-
tor, 1993; Spector, 1993; Misteli et al., 1997; Lamond and
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Earnshaw, 1998). Recent results further point to the involve-
ment of IGCs in coordinating transcription and pre-mRNA
splicing (Misteli and Spector, 1999; Sacco-Bubulya and Spec-
tor, 2002).
On transcriptional elongation, pre-mRNA processing
events are typically initiated immediately, at the site of
transcription (Beyer and Osheim, 1988; Bauren and Wies-
lander, 1994; Proudfoot et al., 2002). The efficient processing
of nascent pre-mRNA is crucial for mRNA biogenesis and is
also a prerequisite for the export of processed mRNA to the
cytoplasm (Custodio et al., 1999; Reed and Hurt, 2002). Nu-
merous in vivo and in vitro studies indicate that RNA pol II
couples transcription and pre-mRNA splicing (Hirose and
Manley, 2000; Maniatis and Reed, 2002; Proudfoot et al.,
2002). Various biochemical studies have established that the
largest subunit of RNA pol II shows differential hyperphos-
phorylation on serine residues within heptad repeats in its
carboxyl-terminal domain (CTD). These modifications reg-
ulate its ability to initiate and elongate transcripts (Bensaude
et al., 1999; Hirose and Manley, 2000; Komarnitsky et al.,
2000) and to interact with specific components of the RNA
processing machinery such as capping enzyme, various
splicing factors, and 3-end cleavage factors (Kim et al., 1997;
McCracken et al., 1997; Ho and Shuman, 1999; Misteli and
Spector, 1999; Komarnitsky et al., 2000; Ryan et al., 2002).
In higher eukaryotes, mitosis is accompanied by dramatic
transformations in the structural organization of both the
cytoplasm and nucleus. The onset of mitosis is accompanied
by chromatin condensation, breakdown of the nuclear en-
velope (John and Workman, 1998), and cessation of bulk
cellular transcription (Prescott and Bender, 1962; Johnson
and Holland, 1965; Gottesfeld and Forbes, 1997). The con-
stituents of many nuclear domains, such as the pre-mRNA
processing factors in nuclear speckles, become distributed
diffusely throughout the cytoplasm (Reuter et al., 1985; Spec-
tor and Smith, 1986; Spector et al., 1991; Ferreira et al., 1994).
During metaphase, pre-mRNA processing factors begin to
reassemble into discrete structures called mitotic interchro-
matin granules (MIGs) (Verheijen et al., 1986; Leser et al.,
1989; Ferreira et al., 1994). MIGs seem to be structurally
analogous to IGCs (Leser et al., 1989; Thiry, 1993, 1995a), and
the number and size of MIGs increase progressively from
metaphase to telophase. However, the function of MIGs has
not been addressed.
The gene expression machinery must be rapidly reacti-
vated when cells exit from mitosis. Because the onset of
transcription in newly formed daughter nuclei relies on the
presence of transcription and RNA processing factors, it is
important to determine when the bulk of these factors reen-
ter daughter nuclei and whether factors are recycled or are
newly translated at the end of mitosis. Herein, we report on
the localization and stability of transcription and pre-mRNA
processing factors during the mitosis/G1 transition. We
found that RNA pol II and its transcription and pre-mRNA
processing factors entered daughter nuclei in a sequential
and nonrandom manner after nuclear envelope/lamina for-
mation. Bromo-UTP incorporation was temporally corre-
lated with the presence of the initiation-competent form of
RNA pol II in daughter nuclei, and it was further enhanced
with increased accumulation of the elongation-competent
form of RNA pol II. The pre-mRNA processing machinery
appeared in daughter nuclei after the entry of the general
transcription factors but just before the appearance of the
elongation competent form of RNA pol II. Interestingly,
transcription and pre-mRNA processing factors had a low
turnover rate during mitosis and were recycled from the
cytoplasm into daughter nuclei. Our data demonstrate that
nuclear entry of the RNA pol II gene expression machinery
after mitosis is a staged process whereby the transcription
apparatus enters in a separate and reproducible window of




Polymerase chain reaction generated a restriction site at the stop
codon of human SC35 cDNA for convenient subcloning into
pEYFP-N1 (BD Biosciences Clontech, Palo Alto, CA). SF2/ASF was
subcloned from GFP-SF2/ASF vector (Misteli et al., 1997) into the
corresponding pEYFP vector.
Cell Culture and Transfection
HeLa cells were grown in DMEM containing low glucose (Invitro-
gen, Carlsbad, CA) supplemented with penicillin-streptomycin and
10% fetal bovine serum (Hyclone Laboratories, Logan, UT). Electro-
poration was performed on trypsinized cells resuspended in 250 l
of growth medium and transferred to cuvettes containing 2 g of
fusion protein plasmid plus 20 g of salmon sperm DNA. Cells
were seeded onto acid-washed coverslips and processed for immu-
nofluorescence localization of nuclear speckle proteins 2 d after
transfection.
Cell Synchronization and Drug Treatments
To obtain large numbers of mitotic cells for protein turnover studies
(Figure 9), HeLa cells were arrested at prometaphase with 50 ng/ml
nocodazole for 14–18 h. Cells were treated with or without cyclo-
heximide 50 g/ml during the final 30 min of nocodazole treatment.
Prometaphase cells were collected and were continuously incubated
in medium either with or without (control) cycloheximide during
release from mitosis. Cells were incubated with [35S]methionine (10
mCi/ml) in cold methionine-free medium for 30 min before collec-
tion. Aliquots of cells were collected at the indicated times (as in
text) and the efficacy of the protein synthesis block was analyzed by
measuring incorporated [35S]methionine by autoradiography. Par-
allel samples were also analyzed by immunoblotting, fluorescence-
activated cell sorting (FACS), and immunofluorescence.
Immunofluorescence
Cells were rinsed briefly in phosphate-buffered saline (PBS) and
then fixed for 15 min in 1.7% formaldehyde in PBS (pH 7.4) or for 5
min in cold methanol (20°C) for optimal penetration of IgM anti-
bodies into nuclei. Cells were permeabilized in PBS containing 0.5%
Triton X-100 and 1% goat serum for 7–10 min on ice, and primary
antibodies were added for 1 h at room temperature: anti-RNA pol II
(8WG16 [1:200], H14 [1:20], H5 [1:20], hnRNP A1 [1:1500], hnRNP
C1/C2 [1:2500], p56 [TFIIE subunit] [1:50], TFIIB [1:300], TFIIF
[RAP74; 1:300], TFIIH [ERCC2, 1:200; ERCC3, 1:100], DRIP130
[1:500], DRIP150 [1:300], TATA binding protein [TBP] [1:50], CstF-64
[1:50], SC35 [1:200], 4G3 anti-B [1:100], mAb103 anti-SF2/ASF
[1:50], SF3a-60 [1:800], lamin B1 [1:500], lamin A/C [1:500], p62
[nuclear pore protein] [1:100], poly (A) binding protein II [PABP II]
[1:200], m3G anti-snRNA [1:50], ubiquitin [1:1500]). Cells were
rinsed in PBS containing 1% goat serum and then secondary anti-
species–specific antibodies (Jackson Immunoresearch Laboratories,
West Grove, PA) were added for 30 min at room temperature: goat
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anti-mouse (GAM) IgG1-Texas Red (1:1000), GAM IgG HL Texas
Red (1:500), GAM IgM-Cy5 (1:1000), goat anti-rat IgG-fluorescein
(1:1200). DNA was stained with 4,6-diamidino-2-phenylindole
(DAPI). Cells were mounted in medium containing 90% glycerol,
10% PBS pH 8.0 plus 1 mg/ml paraphenylenediamine. Cells were
examined using an Axioplan 2i fluorescence microscope (Carl Zeiss,
Thornwood, NY) equipped with Chroma filters (Chroma Technol-
ogy, Brattleboro, VT). OpenLab software (Improvision, Boston, MA)
was used to collect digital images from a ORCA cooled charge-
coupled device camera (Hamamatsu, Bridgewater, NJ).
Bromo-UTP Incorporation
HeLa cells were rinsed briefly in glycerol buffer (20 mM Tris-HCl
pH 7.4, 5.0 mM MgCl2, 25% glycerol, 0.5 mM phenylmethylsulfonyl
fluoride, and 0.5 mM EGTA) followed by permeabilization for 3 min
in glycerol buffer supplemented with 2 g/ml digitonin. Transcrip-
tion buffer (100 mM KCl, 50 mM Tris-HCl pH 7.4, 5 mM MgCl2, 0.5
mM EGTA, 25% glycerol, 1.0 mM phenylmethylsulfonyl fluoride,
2.0 mM ATP, 0.5 mM GTP, 0.5 mM CTP, 0.2 mM 5-bromo-UTP, and
1.0 g/ml RNAsin) was added for 5 min at 37°C. Colocalization of
bromo-UTP (rat anti-bromo, 1:30) and splicing factors was per-
formed as described above.
RNA Fluorescence In Situ Hybridization
To detect splicing of -tropomyosin minigene pre-mRNA, a 24-mer
oligodeoxynucleotide conjugated with a single Texas Red molecule
at the 5 end (Invitrogen) was designed to hybridize to the splice
junction between exons 5 and 6 (5-tgcctggctcggctctcagccacc-3).
Control 12-mer oligos were designed to hybridize to the 3 end of
exon 5 (5-tgcctggctcgg-3) or the 5 end of exon 6 (5-ctctcagccacc-
3). Cells were extracted in CSK buffer (100 mM NaCl, 300 mM
sucrose, 3 mM MgCl2, and 10 mM PIPES pH 6.8) supplemented
with 0.5% Triton X-100 and 2 mM vanadyl ribonucleoside complex.
After immunolabeling as described above, cells were again fixed for
15 min in 2% formaldehyde. Hybridization of oligo probes (1 ng/l)
was performed in 35% deionized formamide, 10% dextran sulfate, 1
mg/ml yeast tRNA, and 2 SSC for 3 h at 37°C. Cells were washed
for 30 min in 25% formamide/2 SSC at 37°C and then 30 min in 2
SSC. Cells were mounted and images obtained using an Axioplan
2i-fluorescence microscope (Carl Zeiss) equipped with Chroma fil-
ters (Chroma Technology) as described above.
Live Cell Microscopy
HeLa cells were transiently transfected with 2 g of YFP-SF2/ASF
or SC35-YFP and live-cell observations were initiated 2 d posttrans-
fection to ensure that fusion protein would be detectable in mitotic
cells. The cells were transferred to an FCS2 live-cell chamber
(Bioptechs, Butler, PA) mounted onto the stage of an IX70 inverted
fluorescence microscope (Olympus, Melville, NY) and kept at 37°C
in L-15 medium (minus phenol red) containing 10% fetal bovine
serum. Time-lapse images acquired with a 100 1.4 numerical
aperture heated objective lens were captured with a Peltier-cooled
IMAGO charge-coupled device camera by using an SVGA interline
chip (1280  1024) with a pixel size of 6.7 m (Till Photonics,
Munich, Germany).
Online Supplemental Materials
Video 1. A HeLa cell in metaphase exhibits a diffuse localization of
YFP-SF2/ASF with a few small MIGs near the metaphase plate. On
entry into anaphase, the number and size of MIGs increases. As
nuclear entry of YFP-SF2/ASF begins, there is a concomitant de-
crease in YFP-SF2/ASF signal in MIGs, consistent with recycling of
splicing factors into newly forming daughter nuclei. Image se-
quences were acquired using TillVision software (Till Photonics)
and animated using QuickTime software. The video is comprised of
a sequence of 260 images. Exposures (20 ms) were collected every
15 s for 65 min.
RESULTS
Components of Transcription and pre-mRNA
Processing Machinery Enter Daughter Nuclei after
Nuclear Envelope/Lamina Formation
One of the earliest events in establishing daughter nuclei
after mitosis is deposition of the nuclear envelope/lamina
around segregated chromosomes (Haraguchi et al., 2000;
Moir et al., 2000; Gerlich et al., 2001; Goldman et al., 2002). To
determine whether the bulk of RNA pol II transcription and
pre-mRNA processing factors associate with daughter nu-
clei before or after nuclear envelope/lamina formation, we
performed coimmunolocalization experiments with anti-
bodies against various transcription or RNA processing fac-
tors and members of the nuclear lamina/nuclear pore com-
plex in asynchronous HeLa cells. The largest subunit of
RNA pol II in its hypo- (Figure 1b) as well as hyperphos-
phorylated (Figure 1, e and h) forms was predominantly
present in the cytoplasm when lamin B1 (Figure 1, c and f)
or nuclear pore complex protein p62 (Figure 1i) had already
localized around the periphery of newly forming daughter
nuclei. Similarly, the largest subunit of transcription factor
TFIIE, p56 (Figure 1k), was not yet detectable in daughter
nuclei at a stage when p62 (Figure 1l) or lamin B1 (our
unpublished data) had already begun to localize at the nu-
clear periphery. Lamins A/C also showed peripheral nu-
clear staining before the entry of RNA pol II and general
transcription factors (data not shown). Next, we examined
the localization of the B protein, an integral component of
the U2 small nuclear (sn)RNP complex (Habets et al., 1989).
In early telophase cells, B was diffusely distributed in the
cytoplasm as well as enriched in MIGs (Figure 1n, arrow).
Similar to RNA pol II and transcription factors, B remained
in the cytoplasm (Figure 1n), whereas the nuclear lamina
and envelope was assembled (Figure 1o). Similar observa-
tions were made with other pre-mRNA splicing factors,
including SF2/ASF and SF3a-60 (our unpublished data). An
antibody that recognizes the trimethyl guanosine cap of
snRNAs (m3G) also showed positive nuclear staining only
after nuclear envelope/lamina formation occurred (our un-
published data). These results clearly indicated that nuclear
envelope/lamina formation occurs before nuclear entry of
various components of the transcription and pre-mRNA
processing machinery.
Initiation-Competent Form of RNA pol II and Its
Associated Transcription Factors Appear in
Daughter Nuclei prior to Nuclear Entry of pre-
mRNA prior to Processing Machinery
Next, we evaluated the sequence of nuclear import of vari-
ous components of the gene expression machinery. First, we
wanted to establish the timing of RNA pol II entry with
regard to entry of transcription and pre-mRNA processing
factors. Antibody 8WG16 (Thompson et al., 1989) predomi-
nantly detects the hypophosphorylated form of the large
subunit of RNA pol II. Antibody H14 (Bregman et al., 1995)
recognizes the hyperphosphorylated ser-5 moiety in the
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CTD repeats, and preferentially recognizes the form of RNA
pol II that is competent for the initiation of transcription
(Komarnitsky et al., 2000). Both the 8WG16 and H14 epitopes
were simultaneously detectable in midtelophase daughter
nuclei (Figure 2, b and c). However, although there was a
negligible amount of cytoplasmic H14 staining (Figure 2b),
there was a significant level of cytoplasmic 8WG16 staining
that persisted until late telophase/early G1 (Figure 2c).
TFIIE entered daughter nuclei at the same time as RNA pol
II (H14; Figure 2, e and f). Similar observations were made
with other general transcription factors, including TFIIB,
TFIIF (RAP 74) and TFIIH (ERCC2, ERCC3) as well as com-
ponents of mediator complex (DRIP 130, 150) (Figure 4).
This differs from the behavior of TBP, a member of the TFIID
complex that was found on the chromosomes throughout
mitosis (our unpublished data) (Chen et al., 2002). Thus,
RNA pol II and multiple components of the transcription
machinery entered daughter nuclei simultaneously during a
narrow temporal window in telophase.
We then compared the import of various pre-mRNA pro-
cessing factors with respect to entry of the transcription
machinery. Interestingly, the bulk of B (Figure 2i) and SR
splicing factor SF2/ASF (Figure 2l) remained localized in the
cytoplasm of telophase cells, intensely concentrated in the
MIGs, even as the ser-5 phosphorylated RNA pol II ap-
peared in the nucleus (Figure 2, h and k). Similarly, splicing
factor SF3a-60 (Schmidt-Zachmann et al., 1998) and the snR-
NAs, as well as hnRNP C1/C2 (Figure 2o) (Pinol-Roma and
Dreyfuss, 1991), hnRNP A1, and PABP II entered the daugh-
ter nuclei after RNA pol II and transcription factors (see
Figure 4 for details). In contrast, the cleavage stimulation
factor CstF-64 entered the daughter nuclei at the same time
as RNA pol II and transcription factors (Figure 2, q and r). In
summary, the hypo- and ser-5–hyperphosphorylated forms
of the large subunit of RNA pol II and its associated factors,
as well as CstF-64 entered the daughter nuclei almost simul-
taneously, prior to entry of the bulk of other pre-mRNA
processing factors.
Figure 1. Nuclear envelope/lamina is assembled before the
entry of components of the gene expression machinery into
daughter nuclei. Both the hypo- (b) and ser-5–phosphory-
lated form of RNA pol II (e) decorate the cytoplasm after the
nuclear lamina formation (c and f). Similarly, colocalization
studies with the ser-5–phosphorylated form of RNA pol II (h)
and nuclear pore protein p62 (i) showed that the nuclear
envelope was established before the nuclear entry of H14.
Transcription factor TFIIE (k) and splicing factor B (n) also
remained in the cytoplasm until after nuclear envelope (l)
and lamina (o) were assembled. Chromosomes were stained
with DAPI (a, d, g, j, and m). Bar 5 m.
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Elongation-Competent Form of RNA pol II Appears
in Daughter Nuclei after Import of RNA Processing
Machinery
Next, we examined the presence in daughter nuclei of the
serine-2 phosphorylated form of RNA pol II, which plays an
essential role in transcriptional elongation (Komarnitsky et
al., 2000) and which is recognized by the H5 antibody (Breg-
man et al., 1995). Ser-2 phosphorylated RNA pol II colocal-
ized with splicing factors in speckles in interphase nuclei
and in the cytoplasmic MIGs in mitotic cells (Bregman et al.,
1994, 1995). This form of RNA pol II remained in the cyto-
plasm (Figure 3, b and e) when hnRNP C1/C2 (Figure 3c)
and hnRNP A1 (Figure 3f) had already appeared in the
daughter nuclei. Splicing factors B (Figure 3i), SF2/ASF
(Figure 3l), and SF3a-60 and m3G-containing snRNPs (our
unpublished data) also appeared in daughter nuclei before
the ser-2 modified form of RNA pol II (Figure 3, h and k).
This result implies that the ser-5 phosphorylated form of
RNA pol II that accumulates in daughter nuclei during
midtelophase is not hyperphosphorylated at the ser-2 moi-
ety until after the pre-mRNA processing machinery has
entered the nuclei (see DISCUSSION).
We extended our analysis to monitor the timing of nuclear
entry of splicing factors vs. other pre-mRNA processing
factors. A schematic diagram of the complete analysis sum-
marizing the data is shown in Figure 4. It was previously
shown that hnRNP C proteins are transported into the
daughter nuclei before hnRNP A1 (Pinol-Roma and Drey-
Figure 2. Appearance of the transcription initiation-compe-
tent form of RNA pol II and associated transcription factors
in postmitotic nuclei precedes pre-mRNA processing factors.
The initiation-competent ser-5 phosphorylated form of RNA
pol II (b and e), hypophosphorylated form of RNA pol II (c)
and TFIIE (f) appeared in daughter nuclei almost simulta-
neously. Splicing factors B (i) and SF2/ASF (l) were largely
localized to the cytoplasmic MIGs (i and l, arrows) when H14
labeling was already apparent in daughter nuclei (h and k).
During this same time period, the hnRNP C1/C2 proteins (o)
were predominantly present in the cytoplasm, whereas H14
had already entered nuclei (n). However, CstF-64 (r) and H14
(q) appeared in daughter nuclei simultaneously. DNA was
stained with DAPI (a, d, g, j, m, and p). Bar 5 m.
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fuss, 1991). In addition, our results showed that splicing
factors (B, SF2/ASF and SF3a) and snRNPs entered daugh-
ter nuclei after hnRNP C1/C2, but prior to hnRNP A1.
However, PABP II and hnRNP A1 entered almost simulta-
neously.
Transcription Machinery Is Active Immediately
upon Nuclear Entry
We were interested in determining whether RNA pol II and
its associated factors immediately begin transcribing RNAs
upon entry into daughter nuclei. To visualize the earliest
active transcription sites in daughter nuclei, HeLa cells were
permeabilized with digitonin and incubated in transcription
buffer containing bromo-UTP for 5 min at 37°C. Before ap-
pearance of RNA pol II in daughter nuclei (H14 epitope;
Figure 5b), transcription was not detectable (Figure 5c).
When RNA pol II (H14 epitope) was first detectable in
daughter nuclei during telophase (Figure 5e), global tran-
scription was detected by bromo-UTP incorporation as faint,
punctate foci throughout the nuclei (Figure 5f), which likely
result from initiation of transcription by ser-5 phosphory-
Figure 3. Transcription elongation competent RNA pol II
appears in daughter nuclei subsequent to the pre-mRNA pro-
cessing machinery. Double-label immunofluorescence by us-
ing antibodies against the ser-2 phosphorylated, elongation-
competent form of RNA pol II (H5) (b, e, h, k, and n) and
hnRNP C1/C2 (c), hnRNP A1 (f), B (i), and SF2/ASF (l and o),
respectively, demonstrated that entry of the pre-mRNA pro-
cessing machinery preceded the appearance of H5 labeling in
daughter nuclei. Splicing factors (i, l, and o) colocalized with
H5 in MIGs (k and l, see arrowhead). SF2/ASF was nearly
absent from MIGs in G1 cells (o, arrow), whereas H5 labeling
was largely retained in MIGs through G1 (n, arrow). DNA was
stained with DAPI (a, d, g, j, and m). Bar, 5 m.
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lated RNA pol II. Daughter nuclei with low levels of elon-
gation-competent RNA pol II (H5; Figure 5h) showed faint
bromo-UTP incorporation in the nucleoplasm, as well as
some bright foci (Figure 5i), the latter of which likely corre-
spond to RNA pol I transcription sites in the nucleolar
organizing regions. With increased amounts of H5 epitope
in daughter nuclei (Figure 5k), bromo-UTP incorporation
increased (Figure 5l), consistent with additional initiation
and transcript elongation at this stage. The increase in nu-
clear H5 signal in late telophase nuclei is probably a result of
the change in hyperphosphorylation (ser-5 to ser-2) of the
CTD of RNA pol II already situated at transcription sites.
The pre-mRNA Splicing Machinery Is Recruited to
Transcription Sites and Is Functional Immediately
upon Nuclear Entry
A HeLa cell line with a stably integrated -tropomyosin
minigene reporter was used to determine whether splicing
factors are competent for pre-mRNA splicing during late
telophase in daughter nuclei. Using an intron-specific oligo-
nucleotide probe to -tropomyosin pre-mRNA, the site of
transcription was localized in interphase nuclei by RNA
fluorescent in situ hybridization (Figure 6c, arrows). Splicing
factors such as SF2/ASF are recruited to this transcription
site during interphase (Figure 6b, arrows). We found that the
-tropomyosin pre-mRNA is also transcribed during late
telophase. To determine whether this newly transcribed pre-
mRNA was being spliced at the transcription site we used a
24-mer splice junction oligonucleotide probe that hybridizes
only to spliced message by virtue of its complementarity to
12 nucleotides at the 3 end of exon 5 and 12 nucleotides at
the 5 end of exon 6. Hybridization of this oligonucleotide in
mitotic cells indicated that splicing factors are competent for
intron excision as early as telophase (Figure 6, f and i,
arrows). Furthermore, we could detect splicing factors such
as SF2/ASF (Figure 6e) and B (Figure 6h) at the transcrip-
tion site immediately upon their entry into daughter nuclei,
before their significant accumulation in the nucleoplasm and
prior to the formation of nuclear speckles. Importantly, we
excluded the possibility that the splice junction probe par-
tially hybridizes to pre-mRNA, via either half of this probe,
because we did not detect hybridization of control 12-mer
oligonucleotides (Figure 6l) in telophase cells in regions
where SF2/ASF has accumulated (Figure 6k, arrow) at what
likely corresponds to the -tropomyosin transcription site.
Release of Splicing Factors from MIGs during
Telophase Is Concurrent with Their Nuclear Entry
The number and size of cytoplasmic MIGs increases when
cells transit from metaphase to telophase. SF2/ASF in MIGs
decreased by late telophase, the time when SF2/ASF entered
the daughter nuclei (compare Figure 3, l and o). Surpris-
ingly, in the same telophase cells, the ser-2 phosphorylated
form of RNA pol II (labeled by H5) persisted in the MIGs
(compare Figure 3, n and o). Other splicing factors such as
U2-snRNP (detected by B) and m3G-containing snRNPs
behaved in a similar manner as SF2/ASF (our unpublished
data). Surprisingly, immunostaining with an antibody
against essential splicing factor SC35 (Fu and Maniatis, 1990)
revealed that it remains in the cytoplasmic MIGs of telo-
phase cells after all modified forms of RNA pol II (detected
by 8WG16, H14, and H5) and other factors of the gene
expression machinery entered daughter nuclei (our unpub-
lished data). However, transient transfection of an SC35
cDNA fused to yellow fluorescent protein (YFP) showed
that SC35-YFP entered daughter nuclei at the same time as
other splicing factors (our unpublished data). The difference
in nuclear entry detected using SC35 antibody vs. SC35-YFP
fusion protein is likely due to the fact that the SC35 antibody
recognizes a subpopulation of SC35 protein, most likely a
specific modified (i.e., phosphorylated) form that enters at a
time point later than other splicing factors. To confirm that
MIGs are not merely protein degradation sites, cells were
immunolabeled with an antibody against ubiquitinated pro-
teins and no positive labeling of MIGs was observed (Figure
7). Taken together, these results indicate that all MIGs have
Figure 4. Schematic representa-
tion of the order of events in the
recruitment of the gene expres-
sion machinery into daughter nu-
clei. A consolidated overview of
sequential entry of transcription
and pre-mRNA processing fac-
tors into newly formed daughter
nuclei.
Transcription and Splicing after Mitosis
Vol. 14, March 2003 1049
a similar composition at a given stage of mitosis, and raises
the possibility that different factors are released from MIGs
at different time points and enter daughter nuclei sequen-
tially. To investigate this further, HeLa cells were transiently
transfected with either YFP-SF2/ASF or SC35-YFP and lo-
calization of the fusion protein was monitored in living
mitotic cells by time-lapse microscopy (Figure 8; see video,
Mitosis.mov). During metaphase, YFP-SF2/ASF was local-
ized in a diffuse cytoplasmic pattern and in addition one to
two small MIGs were routinely observed (Figure 8a). As
mitosis progressed from late-anaphase to early telophase,
the MIGs increased in size and number (Figure 8, b and c).
During midtelophase, YFP-SF2/ASF began to enter daugh-
ter nuclei (Figure 8d) and the MIG signal decreased simul-
taneously (Figure 8, e-h) (see supplementary movie). The
majority of YFP-SF2/ASF protein entered daughter nuclei
within 10 min; however, some faint signal was still detect-
able in MIGs. Similar results were seen with SC35-YFP (our
unpublished data). These results raised the possibility that
during telophase, splicing factors are recycled from the cy-
toplasm (MIGs) into daughter nuclei.
RNA Processing Factors Have a Low Turnover Rate
during Mitosis
As observed in fixed and living cells, the disappearance of
splicing factors from MIGs was coincident with their ap-
pearance in daughter nuclei, suggesting that cycling was
occurring. We pursued this possibility further by addressing
whether the transcription and RNA processing factors found
in the newly formed daughter nuclei were synthesized just
after mitosis, or whether they were recycled from the pre-
existing cytoplasmic population. We arrested HeLa cells at
prometaphase with the microtubule disrupting drug no-
codazole, and then subsequently released the cells from
mitotic arrest either in the presence or absence of the protein
Figure 5. Global transcription increases with accumulation of
the ser-2 phosphorylated form of RNA pol II in daughter
nuclei. Double-label immunofluorescence by using antibodies
against ser-5 phosphorylated (H14) (b and e) or ser-2 phos-
phorylated RNA pol II (H5) (h and k) and bromo-UTP (c, f, i,
and l) shows that there is no transcription in daughter nuclei
prior to entry of RNA pol II (b and c). When ser-5 phoshory-
lated RNA pol II begins to enter daughter nuclei there is only
a low level of nucleoplasmic bromo-UTP incorporation (e and
f), similar to the presence of low levels of ser-2 phosphorylated
RNA pol II (h and i). With further accumulation of the ser-2
phosphorylated RNA pol II, bromo-UTP incorporation dra-
matically increased (k and l). DNA was stained with DAPI (a,
d, g, and j). Bar, 5 m.
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synthesis inhibitor cycloheximide (see MATERIALS AND
METHODS). Cells were collected over a time course and
total cellular proteins were subjected to SDS-PAGE. The
Coomassie Blue staining (Figure 9a) showed the level of
proteins in each lane and the corresponding [35S]methionine
incorporation (Figure 9b) revealed a complete inhibition of
protein synthesis in the cells incubated with cycloheximide
(Figure 9b, lanes 2, 4, and 6). Cell cycle progression was
monitored by assaying the DNA content of propidium io-
dide stained cells by FACS (Figure 9c). It was clear that in
the absence of protein synthesis, the majority of cells pro-
gressed normally through the cell cycle and entered G1, as
determined by FACS and phase contrast microscopy (data
not shown). Immunoblot analysis was carried out with the
above-mentioned samples by using antibodies against vari-
ous splicing factors (SF2/ASF and B), CstF-64, hnRNP A1,
hnRNP C1/C2, and different forms of RNA pol II (8WG16,
H14, and H5) (Figure 9d). These results showed that there is
not a significant turnover of the components of the pre-
mRNA splicing and RNA processing machinery during mi-
tosis (Figure 9d, lanes 1–4). A similar low turnover rate was
observed for the RNA pol II transcription factors TFIIB and
TBP (our unpublished data). Consistent with this finding,
the recruitment of factors into daughter nuclei as observed
by immunofluorescence was similar in the presence or ab-
sence of cycloheximide (data not shown). Note that as the
cells progressed into G1, there was a fresh round of protein
synthesis as seen by the quantitative difference in protein
levels as detected by immunostaining after 4 h of release
from nocodazole arrest with or without cycloheximide (Fig-
ure 9d, compare SF2/ASF, B, CstF-64, and hnRNP C1/C2
between lanes 5 and 6). -Tubulin and cyclin A are shown as
internal controls for equal protein loading and cell cycle
progression, respectively. These results conclusively demon-
strate that transcription factors and splicing factors have a
low rate of turnover during mitosis, and it is the preexisting
population of proteins that is recycled into daughter nuclei
during the transition from mitosis to G1.
DISCUSSION
A physical coupling between transcription and pre-mRNA
processing components is now thought to be instrumental
for efficient gene expression (Maniatis and Reed, 2002). Dur-
ing mitosis, there is a global shut down of gene expression,
due at least in part to the hyperphosphorylation of a large
number of proteins involved in this process and resulting in
Figure 6. Splicing factors are functionally compe-
tent upon entry into daughter nuclei. RNA fluores-
cence in situ hybridization was performed on
HeLa cells stably expressing a -tropomyosin
minigene. The locus is detected during interphase
as a single dot (c, arrow) that recruits splicing
factors such as SF2/ASF (b, arrow). During telo-
phase, SF2/ASF (e) and B (h) are recruited to the
locus, which is detected by a splice junction probe
(SJ) (f and i), demonstrating that splicing occurs at
this stage. Control hybridization of 12-mer oligo-
nucleotides (l) shows no hybridization signal at
loci decorated with SF2/ASF (k, arrow indicates
probable transcription site). DNA was stained with
DAPI (a, d, g, and j). Bar, 5 m.
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the disassembly of many cellular structures (Gottesfeld and
Forbes, 1997). A problem confronted by the mitotic cell is the
establishment of the gene expression machinery in daughter
nuclei so that these cells become competent to undergo
transcription/RNA processing as they exit from mitosis. To
investigate whether components of the gene expression ma-
chinery enter the postmitotic nuclei individually or as a
unitary complex, we used immunofluorescence and live cell
imaging to monitor the dynamics of these factors from mi-
tosis to G1. We have demonstrated that transcription and
pre-mRNA splicing factors enter the nuclei sequentially, not
as a unitary complex, after nuclear envelope/lamina forma-
tion. This ordered entry of transcription factors prior to
pre-mRNA splicing factors seems to be a general phenom-
enon because we have observed similar results in trans-
formed cells (HeLa) as well as in cells of defined passage
number (IMR90). Furthermore, we have shown that telo-
phase nuclei are competent for transcription and pre-mRNA
splicing immediately upon reentry of the gene expression
machinery. The present study also established a low turn-
over of transcription and pre-mRNA splicing factors during
mitosis demonstrating that the preexisting population of
proteins recycled into daughter nuclei as the cells progress
through telophase.
The nuclear envelope/lamina of higher eukaryotes breaks
down during prophase and is reconstituted around chromo-
somes during late anaphase to telophase, reestablishing the
boundary of the interphase nucleus (Haraguchi et al., 2000;
Goldman et al., 2002). Our observations that import of tran-
scription and pre-mRNA processing factors into daughter
nuclei occurs after the nuclear envelope and lamina are
assembled suggests that import occurs through nuclear pore
complexes by active transport, because many of the pres-
ently studied proteins are above the size exclusion for transit
by diffusion (Adam, 1999). Although all the members of the
RNA pol II gene expression machinery do not enter newly
formed daughter nuclei as a unitary complex, we cannot
exclude the possibility that groups of some of these proteins
enter as heterotypic complexes. Although the nuclear entry
of these factors coincides with activation of transcription in
daughter nuclei, transcription inhibition does not interfere
with entry of most of these proteins (Ferreira et al., 1994),
with the exception of hnRNP A1, which is known to be
retained in the cytoplasm of transcriptionally inhibited post-
mitotic cells (Pinol-Roma and Dreyfuss, 1991).
Immunolabeling with specific antibodies that detect the
largest subunit of RNA pol II clearly shows that hypo- and
ser-5–phosphorylated RNA pol II appear in daughter nuclei
before the ser-2 phosphorylated form of RNA pol II. CTD
phosphorylation at ser-2 and ser-5 represents an important
regulatory mechanism for coordinating RNA pol II activity
(West and Corden, 1995; Bensaude et al., 1999). Phosphory-
lation of the CTD occurs soon after initiation of transcription
and is necessary for interaction of RNA pol II with other
RNA processing factors (Hirose and Manley, 2000). Studies
from various laboratories suggest that RNA pol II with a
hypophosphorylated CTD is preferentially included in the
transcription preinitiation complex formed at the promoter.
Once bound to the promoter, the CTD is phosphorylated at
ser-5 and becomes initiation competent (Komarnitsky et al.,
2000; Cho et al., 2001). Chromatin immunoprecipitation
studies showed that the phosphorylated ser-5 (H14) epitope
persists until RNA pol II transcribes up to 200 nucleotides
downstream of the promoter, at which time the ser-5 phos-
phate is either removed or the CTD is further modified in a
way that blocks the H14 epitope (Komarnitsky et al., 2000).
On the other hand, the ser-2 (H5) epitope was not detected
on RNA pol II at the promoter, but was detected on the
polymerase in the coding regions of the genes studied lead-
ing to the interpretation that it is the elongation competent
form of the polymerase (Komarnitsky et al., 2000). Our study
revealed that the initiation competent form of RNA pol II
appeared in daughter nuclei almost simultaneously with
other transcription factors but before splicing factors. Dual
immunostaining studies with 8WG16 and H14 revealed the
concomitant presence of these two forms of RNA pol II in
the daughter nuclei. However, we have not been able to
determine whether appearance of the ser-5 (H14) phosphor-
ylated form of RNA pol II in daughter nuclei is a conse-
quence of entry of this modified form from the cytoplasmic
population or whether the unphosphorylated form enters
the nucleus and is subsequently phosphorylated. Nocoda-
Figure 7. MIGs are not protein degradation sites. Immunostaining with an antibody against ubiquitinated proteins (c) did not reveal any
positive labeling of MIGs but predominantly labeled the midbody between daughter cells. MIGs were positively stained with the elongation
competent form of RNA pol II, H5 (b). DNA was stained with DAPI (a). Bar, 5 m.
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zole block and release in the presence or absence of cyclo-
heximide showed that the level of all forms of RNA pol II
was constant from M phase to G1. Continuous oscillation of
phosphorylation/dephosphorylation of RNA pol II makes it
difficult to address the issue of recycling of the ser-5 modi-
fied form. However, phosphorylation at ser-5 may occur in
daughter nuclei because it is the hypophosphorylated form
of RNA pol II that is preferentially detected at the preinitia-
tion complex at the promoter (Hirose and Manley, 2000).
Consistent with this, we observed that a subpopulation of
postmitotic nuclei positive for the ser-5 phosphorylated
form of RNA pol II and other transcription factors showed
weak bromo-UTP incorporation, suggesting that only initi-
ation of transcription was occurring in these cells at this time
point. In support of this possibility, those cells that showed
weak bromo-UTP incorporation also showed weak to no H5
immunolabeling, leading us to speculate that the RNA pol II
present in these nuclei is not the elongation competent form.
Furthermore, we observed that the level of bromo-UTP in-
corporation increased dramatically in cells showing intense
H5 labeling.
An important question concerning the organization of the
gene expression machinery during cell division concerns the
timing of import of various transcription and RNA process-
ing factors into daughter nuclei with respect to activation of
transcription and splicing in these cells. Our data demon-
strate that the transcription apparatus reproducibly enters
daughter nuclei independently of pre-mRNA splicing fac-
tors, which are recruited into daughter nuclei after transcrip-
tion is initiated. Therefore, a mechanism must exist to coor-
dinate transcription and pre-mRNA splicing during the
transition from telophase to the establishment of the inter-
phase nucleus. Nuclear speckles have been suggested to
play a role in coupling transcription and pre-mRNA splicing
in mammalian interphase nuclei (Misteli and Spector, 1999;
Sacco-Bubulya and Spector, 2002). Although MIGs have
been proposed to be the mitotic equivalent of nuclear speck-
les, their function in mitotic cells has not been addressed
(Leser et al., 1989; Thiry, 1995a,b). In telophase cells, some
MIGs were found to be in proximity to the newly formed
nuclear envelope. This proximity of MIGs to the nuclear
periphery and the disappearance of MIGs in late telophase
cells with the appearance of IGCs in daughter nuclei have
suggested that the MIGs might be directly transported into
the nuclei (Leser et al., 1989; Thiry, 1995a,b). However, co-
localization of SF2/ASF and RNA pol II (H5) in MIGs of late
telophase cells (Figure 3, j–o) clearly shows that various
components of MIGs are differentially released for subse-
quent entry into the nucleus, whereas some factors such as
modified forms of SC35 and RNA pol II (H5) still maintain
a subpopulation in MIGs until G1. This result raises the
possibility that MIGs might be playing important roles ei-
ther in modification of the components of the splicing ma-
chinery before their nuclear entry, or as enriched popula-
tions of these factors allowing for protein–protein
interactions to occur between subsets of proteins before their
nuclear entry.
Our data demonstrating that splicing factors are compe-
tent for pre-mRNA splicing immediately upon entry into
daughter nuclei supports the possibility that MIGs may be
responsible for splicing factor modification, allowing for
immediate targeting of modified RNA processing complexes
Figure 8. Live cell observations of entry of SF2/ASF into daughter cell nuclei. HeLa cells were transiently transfected with YFP-SF2/ASF
and live-cell observations were initiated 2 d posttransfection. Metaphase cells exhibit one to two MIGs near the metaphase plate (a, arrow).
As the cell enters anaphase, MIGs become more abundant (b and c). SF2/ASF begins to enter daughter nuclei at telophase (d). Nuclear entry
of YFP-SF2/ASF is nearly complete in 20 min (h). Time is indicated in min from the initiation of imaging the metaphase cell (see video,
Mitosis.mov).
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to transcription sites in telophase nuclei. Because daughter
nuclei late in telophase have not yet assembled nuclear
speckles, cytoplasmic MIGs are likely to function as their
counterparts to provide competent pre-mRNA splicing fac-
tors to the initial sites of transcription in newly formed
nuclei. Perhaps splicing factors are released from MIGs via
hyperphosphorylation as has been demonstrated for their
release from nuclear speckles in interphase nuclei. Of par-
ticular interest in this regard are two kinase families, SR
protein specific kinases, including SRPK1, 2 and cdc2-like
kinases (Clk/STY 1–4) that have been shown to specifically
phosphorylate the RS domains of SR splicing factors (How-
ell et al., 1991; Colwill et al., 1996a,b; Wang et al., 1998a,b;
Yeakley et al., 1999). Although Clk/STY has been shown to
modulate the localization of SR proteins in interphase nuclei
(Colwill et al., 1996a,b; Sacco-Bubulya and Spector, 2002),
SRPK family has been implicated in the reorganization of
splicing factors associated with mitosis (Gui et al., 1994a,b).
Future studies will address the role of SRPK or Clk/STY
family members in the release of splicing factors from MIGs,
thereby making them available to enter daughter nuclei.
Our study provides two lines of evidence to support
recycling of MIG constituents (splicing factors) during mi-
tosis. First, observation of YFP-tagged splicing factors in
living cells demonstrates a decrease in the MIG population
of splicing factors concomitant with an increase in the nu-
clear population of these factors. Second, we demonstrate
that there is a low turnover rate of protein constituents of the
splicing machinery during mitosis, suggesting recycling of a
preexisting population into newly formed daughter nuclei.
Based upon these observations, we propose a direct role for
MIGs in recycling of splicing factors during mitosis. Our
data are consistent with the possibility that proteins and/or
protein complexes are released from MIGs for subsequent
entry into daughter nuclei. Future studies will examine this
possibility in living cells.
Our results demonstrating that the entry of RNA pol II,
transcription and pre-mRNA processing factors into postmi-
totic daughter nuclei is a staged process that occurs after the
deposition of nuclear envelope/lamina, suggests the exis-
tence of a possible regulatory mechanism, at the level of
nuclear import for each class of these factors, as the cells exit
mitosis. Facilitated transport of proteins into the nucleus
requires the presence of signal motifs, nuclear localization
signals (NLSs), which are recognized by specific soluble
shuttling receptors of the importin/karyopherin family
(Mattaj and Englmeier, 1998; Kuersten et al., 2001). Nuclear
import of proteins with a classical basic NLS is mediated by
the dimeric complex of importin /, of which the impor-
tin- subunit binds to the NLS directly and serves as the
adaptor to importin- (Jans et al., 2000). The importin-
receptor facilitates nuclear translocation by binding to nu-
clear pore proteins and Ran GTPase in conjunction with
other proteins leading to nuclear import. To date, many
Figure 9. RNA processing fac-
tors exhibit a low turnover rate
during mitosis. Cells blocked in
prometaphase by nocodazole
treatment were incubated with
(N  C) or without (N) cyclohex-
imide and pulsed with [35S]me-
thionine during release from the
mitotic block. Aliquots of cells
were collected at indicated times
and efficacy of the protein synthe-
sis block was analyzed by mea-
suring incorporated [35S]methi-
onine by autoradiography (b)
(see MATERIALS AND METH-
ODS). The corresponding Coom-
assie-stained gel is shown in a.
Lanes 1, 3, and 5 are cells treated
with nocodazole for 14–18 h and
collected at 1, 2, and 4 h postre-
lease, respectively. Lanes 2, 4,
and 6 represent cells treated with
nocodazole and cycloheximide at
indicated time points. Lanes 7
and 8 represents nocodazole-ar-
rested cells and an asynchronous
population, respectively. DNA
content of the respective cell pop-
ulations indicated in d, 1–8, was
determined by FACS analysis
and is shown in c. Cells treated
with or without cycloheximide
were collected at indicated time
points and extracted for immuno-
blot analysis of components of the gene expression machinery (d). The results show a low turnover of splicing factors (SF2/ASF and B),
CstF-64, hnRNP A1, hnRNPC1/C2, and various forms of RNA pol II during mitosis. Tubulin and cyclin A are shown as internal controls for
protein loading and cell cycle progression, respectively.
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nonprototypical NLSs have been reported (Nakielny and
Dreyfuss, 1999). The well-characterized nonclassical NLS is
the M9 sequence of hnRNP A1 (Siomi and Dreyfuss, 1995).
M9-dependent import is mediated by transportin 1, which is
related to importin-. Similarly, the majority of the SR pro-
teins are imported into the nuclei with the help of two
different importins-, transportin SR1 (TRN-SR1) and trans-
portin SR2 (TRN-SR2) (Kataoka et al., 1999; Lai et al., 2000).
TRN-SR2 mediates the nuclear import of phosphorylated SR
proteins (Lai et al., 2001; Allemand et al., 2002), suggesting
that differentially modified proteins could be imported by
independent mechanisms by different importin receptors
(Nakielny and Dreyfuss, 1999). It is tempting to speculate
that the differential entry of RNA pol II transcription and
pre-mRNA processing factors at the end of mitosis could be
the result of regulated interactions with various importin
superfamily members. This possibility will be pursued in
future studies.
The coupling of the transcription and pre-mRNA process-
ing machinery is clearly an important aspect of accurate
gene expression. Our data provides important insight with
regard to how the gene expression machinery is recruited
into daughter nuclei at the end of mitosis. To our surprise,
the gene expression machinery did not enter daughter nuclei
in a stochastic manner but instead components entered in a
reproducible sequence. It is possible that this sequential
recruitment of proteins into daughter nuclei establishes fa-
vorable cues for transcription initiation within the context of
the decondensing chromosomes. The formidable challenge
will be to identify the critical signals that trigger this sequen-
tial recruitment.
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